The University of Queensland

Phase 1 trial of autologous Epstein-Barr virus-specific T cell therapy as treatment of progressive multiple sclerosis (2016–2017)

Grant type:

Queensland Institute of Medical Research

Researchers:

• 

  Emeritus Professor Michael Pender

  Emeritus Professor
  

  Royal Brisbane Clinical Unit

  Faculty of Medicine

Funded by:

Queensland Institute of Medical Research